Skip to content
GLP-1 Savers
Menu

Head-to-head · Value Score

bmiMD vs Revive Meds

Two GLP-1 deals, scored on the same six factors. bmiMD lands a Value Score of 89, Revive Meds a 60. Here's who gives you the honest lower price — and where each one bites back.

★ Better value

bmiMD

#11 · Grade A · Great Deal

Est. first month

$99/mo

Save ~93% vs brand-name
Get this deal Full bmiMD review →
VS

Revive Meds

#362 · Grade C · Watch List

Est. first month

From $369/mo (starting dose, compounded)

Save ~73% vs brand-name
Get this deal Full Revive Meds review →

The verdict

Better value: bmiMD

bmiMD takes it on Value Score, 89 to 60 an est. $99/mo first month, with no teaser step-up baked in. Revive Meds isn't out of it: Shoppers who want pay-per-order compounded GLP-1 (with B12) buyers who prepay multi-month for the lowest per-month cost.

Our #1 overall:Neither of these is our top pick — that's CoreAge Rx (Value Score 93).See why →

Deal-by-deal

The numbers that decide it. Green ✓ marks the stronger side on each line.

DealbmiMDRevive Meds
Value Score89 (A)60 (C)
Est. first month$99/moFrom $369/mo (starting dose, compounded)
Save vs brand-name~93%~73%
Semaglutide$99/moFrom $369/mo (starting dose, compounded)
Tirzepatide$139/moFrom $459/mo (starting dose, compounded)
Both moleculesYesYes
PricingFlat — no step-upWatch
CoverageAll 50 statesAll 50 states

Factor by factor

The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.

95
Lowest Real Price
38
bmiMD: 95. Revive Meds: 38.
84
No Teaser-Rate Bait
30
bmiMD: 84. Revive Meds: 30.
98
Nationwide Availability
96
bmiMD: 98. Revive Meds: 96.
94
Both Molecules
92
bmiMD: 94. Revive Meds: 92.
82
Easy Cancellation
95
bmiMD: 82. Revive Meds: 95.
70
Reputation
78
bmiMD: 70. Revive Meds: 78.

bmiMD

Sub-$100 semaglutide and a low $139 tirzepatide, flat and nationwide — a straight-up low-price play.

Why it's a deal

  • $99 flat semaglutide and a low $139 tirzepatide
  • Available in all 50 states
  • Both molecules priced up front

The fine print

  • Not LegitScript-certified — do your own pharmacy diligence
  • Thin public track record; no oral or brand-name option

Revive Meds

Revive Meds (revive-meds.com, Revive Health Therapy) is a nationwide GLP-1 and longevity telehealth service that sells compounded semaglutide and dual-agonist tirzepatide, each combined with vitamin B12…

Why it's a deal

  • Offers both compounded semaglutide and dual-agonist tirzepatide, each combined with vitamin B12 (cyanocobalamin) in a single injection
  • Pay-per-order model with no subscription, sign-up fees, or long-term commitment, and free shipping on every order
  • Names its six 503A compounding pharmacies and two prescribing physicians, which is unusually transparent on fulfillment
  • Available in all 50 states and HSA/FSA eligible through a Medical Necessity Letter
  • Prepaying 3 to 12 months cuts the effective cost to as low as $202/mo (semaglutide) or $300/mo (tirzepatide)

The fine print

  • Month-to-month pricing is steep: $369/mo semaglutide and $459/mo tirzepatide unless you prepay several months
  • No public price list; pricing appears only after you complete a full health intake and create an account
  • Not LegitScript-certified (no seal displayed on the site)
  • Compounded semaglutide and tirzepatide are not FDA-approved finished products
Get the bmiMD deal Get the Revive Meds deal

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.

Neither one the right fit? Every program that outscores bmiMD is ranked on the bmiMD alternatives board, and the same list for the other side is on alternatives to Revive Meds.

More head-to-heads

← All comparisons

Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.